Results 231 to 240 of about 105,659 (312)

Reply to "comment on: Transrectal prostate biopsy complications: a prospective single center study in a mid-income country". [PDF]

open access: yesEinstein (Sao Paulo)
Schollemberg AJ   +7 more
europepmc   +1 more source

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

open access: yes
BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang   +10 more
wiley   +1 more source

Same‐day fluorescence confocal microscopy of MRI‐targeted prostate biopsies: A feasibility study

open access: yesBJU International, EarlyView.
Objectives To determine the diagnostic performance of ex vivo fluorescence confocal microscopy (FCM) for prostate cancer detection in magnetic resonance imaging (MRI)‐targeted biopsy specimens using final histopathology as the reference standard, and to quantify workflow component times relevant to same‐day implementation.
Salim K. Younis   +13 more
wiley   +1 more source

Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study. [PDF]

open access: yesEur Urol Open Sci
Ventimiglia E   +7 more
europepmc   +1 more source

Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach

open access: yesBJU International, EarlyView.
Objectives To evaluate whether a simplified risk model preserves the prognostic performance of the International Bladder Cancer Group (IBCG) five‐factor risk stratification model in intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We performed a multicentre retrospective analysis of 2822 patients with IR NMIBC ...
Jayant Siva   +12 more
wiley   +1 more source

Micro‐ultrasonography‐ vs MRI‐targeted biopsy in prostate cancer: Updated systematic review and meta‐analysis

open access: yesBJU International, EarlyView.
Objective To refine prostate cancer (PCa) pathways by comparing micro‐ultrasonography‐targeted biopsy (micro‐US‐TBx) with magnetic resonance imaging (MRI)‐TBx for detecting clinically significant PCa (csPCa) and by evaluating diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value).
José Pedro Cassemiro Micheleto   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy